July 31 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab said on Wednesday that additional data on patients, beyond what was initially identified, had been stolen in a cyberattack ...

Cencora has so far notified over a million ... per a list of data breaches published by the U.S. Department of Health and Human Services (HHS). Although the number of affected individuals has ...

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.

Shares of Cencora COR lost 3.9% on Jun 27, followed by another 1.3% decline during the after-hours trading. This was likely due to the invalidation of a previously-settled opioid litigation by the ...

Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter ...